title: [Prognosis and long-term results of treatment of patients with differentiated thyroid carcinoma].
abstract: Results of treatment of 67 patients with differentiated thyroid carcinoma were analyzed. Pathological changes in the thyroid residue structure were found in 42.3% of patients after subtotal resection of the thyroid gland (SRTG), 38.8% of the total number of patients were given inadequate suppressive therapy. Only 63.4% of women with thyroid carcinoma were found to have pathology of organs of the reproductive system. SRTG is thought to be an unreasonable volume of operative treatment. For the determination of strategy of treatment it is expedient to use the systems of risk assessment of MACIS, TNM, Clinical Class (University of Chicago).
authors.forename: V M
authors.initials: VM
authors.lastname: Sedov
authors.forename: V A
authors.initials: VA
authors.lastname: Khmelevskaia
mesh_terms: D018263:Adenocarcinoma, Follicular; D000368:Aged; D000369:Aged, 80 and over; D044963:Biopsy, Fine-Needle; D002277:Carcinoma; D002291:Carcinoma, Papillary; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D017613:Iodine Compounds; D007456:Iodine Isotopes / Q000627:therapeutic use*; D008297:Male; D008991:Monitoring, Physiologic; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D018570:Risk Assessment; D016019:Survival Analysis; D000077273:Thyroid Cancer, Papillary; D013961:Thyroid Gland / Q000473:pathology / Q000528:radiation effects / Q000601:surgery; D013964:Thyroid Neoplasms / Q000473:pathology / Q000628:therapy; D013965:Thyroidectomy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D017613:Iodine Compounds; D007456:Iodine Isotopes